Literature DB >> 15265097

Substance abuse treatment needs and access in the USA: interstate variations.

William E McAuliffe1, Ryan Dunn.   

Abstract

AIMS: This study investigated interstate substance abuse treatment needs and access in the USA.
DESIGN: After assessing the validity of recently developed survey and indicator measures, the study analysed the geographic distribution and nature of state substance abuse treatment needs. Substance abuse treatment utilization index scores were regressed on the need measurements to identify differences among state populations in treatment access.
FINDINGS: The interstate substance abuse treatment need measures had evidence of reliability and construct validity. Treatment needs clustered in stable, distinct geographic patterns. The most severe problems, primarily reflecting alcoholism, were in the west. Drug and alcohol substance use disorders and related problems were not significantly correlated at this level of aggregation. There was evidence of regionalization of the drug-of-choice mix in treatment admissions. Only 21% of the variations in state treatment utilization rates stemmed from the prevalence of substance use disorders and related problems. The biggest treatment gaps were in the south and south-west, regions with large minority populations.
CONCLUSIONS: Development of interstate survey and indicator measures of treatment needs has created new opportunities to broaden our understanding of substance abuse epidemiology and treatment access in the USA. The nature and severity of drug and alcohol problems vary from state to state, but the interstate disparities in treatment services remain even after variations in treatment need have been discounted. Further research is needed to understand the causes of these differences in treatment access.

Entities:  

Mesh:

Year:  2004        PMID: 15265097     DOI: 10.1111/j.1360-0443.2004.00783.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  17 in total

1.  Correlates of participation in peer recovery support groups as well as voluntary and mandated substance abuse treatment among rural and urban probationers.

Authors:  Carrie B Oser; Kathi L H Harp; Dan J O'Connell; Steve S Martin; Carl G Leukefeld
Journal:  J Subst Abuse Treat       Date:  2011-08-11

2.  Emergency commitment of people residing in assisted living facilities.

Authors:  Annette Christy; Victor Molinari
Journal:  Community Ment Health J       Date:  2011-01-15

3.  Geographic Disparities in Availability of Opioid Use Disorder Treatment for Medicaid Enrollees.

Authors:  Amanda J Abraham; Christina M Andrews; Marissa E Yingling; Jerry Shannon
Journal:  Health Serv Res       Date:  2017-03-27       Impact factor: 3.402

4.  County-level access to opioid use disorder medications in medicare Part D (2010-2015).

Authors:  Amanda J Abraham; Grace Bagwell Adams; Ashley C Bradford; William D Bradford
Journal:  Health Serv Res       Date:  2019-01-21       Impact factor: 3.402

5.  Community context and healthcare quality: the impact of community resources on licensing and accreditation of substance abuse treatment agencies.

Authors:  Matthew E Archibald; Caddie Putnam Rankin
Journal:  J Behav Health Serv Res       Date:  2013-10       Impact factor: 1.505

6.  Substance abuse treatment utilization among adults living with HIV/AIDS and alcohol or drug problems.

Authors:  John Orwat; Richard Saitz; Christopher P Tompkins; Debbie M Cheng; Michael P Dentato; Jeffrey H Samet
Journal:  J Subst Abuse Treat       Date:  2011-06-22

7.  Predictors of substance abuse treatment entry among rural illicit stimulant users in Ohio, Arkansas, and Kentucky.

Authors:  Robert G Carlson; Rocky Sexton; Jichuan Wang; Russel Falck; Carl G Leukefeld; Brenda M Booth
Journal:  Subst Abus       Date:  2010-01       Impact factor: 3.716

8.  Patterns in admission delays to outpatient methadone treatment in the United States.

Authors:  Jan Gryczynski; Robert P Schwartz; David S Salkever; Shannon Gwin Mitchell; Jerome H Jaffe
Journal:  J Subst Abuse Treat       Date:  2011-08-06

9.  Barriers to the implementation of medication-assisted treatment for substance use disorders: the importance of funding policies and medical infrastructure.

Authors:  Hannah K Knudsen; Amanda J Abraham; Carrie B Oser
Journal:  Eval Program Plann       Date:  2011-03-02

10.  Development of the drug-exposed infant identification algorithm (DEIIA) and its application to measuring part C early intervention referral and eligibility in Massachusetts, 1998-2005.

Authors:  Taletha Mae Derrington
Journal:  Matern Child Health J       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.